Measurement of endocrine activity (SET2,3) related to prognosis and prediction of benefit from dose-dense chemotherapy in estrogen receptor-positive (ER+) cancer: correlative analysis of C9741 (Alliance).
- Citation:
- J Clin Oncol vol 40 (16 supp;) 505
- Meeting Instance:
- ASCO 2022
- Year:
- 2022
- Type:
- Abstract
- Sub type:
- Poster/Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 4208